Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease
- PMID: 20008657
- PMCID: PMC2837584
- DOI: 10.1001/archneurol.2009.267
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease
Abstract
Objective: To determine the motor phenotype of LRRK2 G2019S mutation carriers. LRRK2 mutation carriers were previously reported to manifest the tremor dominant motor phenotype, which has been associated with slower motor progression and less cognitive impairment compared with the postural instability and gait difficulty (PIGD) phenotype.
Design: Cross-sectional observational study.
Setting: Thirteen movement disorders centers.
Participants: Nine hundred twenty-five early-onset Parkinson disease cases defined as age at onset younger than 51 years.
Main outcome measures: LRRK2 mutation status and Parkinson disease motor phenotype: tremor dominant or PIGD. Demographic information, family history of Parkinson disease, and the Unified Parkinson's Disease Rating Scale score were collected on all participants. DNA samples were genotyped for LRRK2 mutations (G2019S, I2020T, R1441C, and Y1699C). Logistic regression was used to examine associations of G2019S mutation status with motor phenotype adjusting for disease duration, Ashkenazi Jewish ancestry, levodopa dose, and family history of Parkinson disease.
Results: Thirty-four cases (3.7%) (14 previously reported) were G2019S carriers. No other mutations were found. Carriers were more likely to be Ashkenazi Jewish (55.9% vs 11.9%; P < .001) but did not significantly differ in any other demographic or disease characteristics. Carriers had a lower tremor score (P = .03) and were more likely to have a PIGD phenotype (92.3% vs 58.9%; P = .003). The association of the G2019S mutation with PIGD phenotype remained after controlling for disease duration and Ashkenazi Jewish ancestry (odds ratio, 17.7; P < .001).
Conclusion: Early-onset Parkinson disease G2019S LRRK2 carriers are more likely to manifest the PIGD phenotype, which may have implications for disease course.
Conflict of interest statement
Similar articles
-
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Mov Disord. 2013 Dec;28(14):1966-71. doi: 10.1002/mds.25647. Epub 2013 Oct 15. Mov Disord. 2013. PMID: 24243757 Free PMC article.
-
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.Parkinsonism Relat Disord. 2015 Feb;21(2):106-10. doi: 10.1016/j.parkreldis.2014.09.033. Epub 2014 Nov 20. Parkinsonism Relat Disord. 2015. PMID: 25434972 Free PMC article.
-
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.Mov Disord. 2015 Feb;30(2):253-8. doi: 10.1002/mds.26097. Epub 2014 Dec 9. Mov Disord. 2015. PMID: 25487881
-
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.J Neural Transm (Vienna). 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0. J Neural Transm (Vienna). 2009. PMID: 19756366 Review.
-
The heterozygous R1441C mutation of leucine-rich repeat kinase 2 gene in a Chinese patient with Parkinson disease: A five-year follow-up and literatures review.J Neurol Sci. 2017 Feb 15;373:23-26. doi: 10.1016/j.jns.2016.12.009. Epub 2016 Dec 9. J Neurol Sci. 2017. PMID: 28131193 Review.
Cited by
-
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.Front Aging Neurosci. 2015 Jan 9;6:340. doi: 10.3389/fnagi.2014.00340. eCollection 2014. Front Aging Neurosci. 2015. PMID: 25620929 Free PMC article. Review.
-
Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.Front Aging Neurosci. 2018 Sep 19;10:283. doi: 10.3389/fnagi.2018.00283. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30283330 Free PMC article.
-
Generalized dystonia without Parkinsonism in an LRRK2 carrier.Clin Park Relat Disord. 2022 Jul 21;7:100157. doi: 10.1016/j.prdoa.2022.100157. eCollection 2022. Clin Park Relat Disord. 2022. PMID: 35941989 Free PMC article. No abstract available.
-
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease.J Neurosurg. 2021 Nov 19;137(1):184-191. doi: 10.3171/2021.7.JNS21190. Print 2022 Jul 1. J Neurosurg. 2021. PMID: 34798606 Free PMC article.
-
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Mov Disord. 2013 Dec;28(14):1966-71. doi: 10.1002/mds.25647. Epub 2013 Oct 15. Mov Disord. 2013. PMID: 24243757 Free PMC article.
References
-
- Lesage S, Durr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs. N Engl J Med. 2006;354(4):422–423. - PubMed
-
- Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786–1791. - PubMed
-
- Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N Engl J Med. 2006;354(4):424–425. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials